BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioCancell Therapeutics 

Beck Science Center
8 Hartom Street, Har Hotzvim
Jerusalem    97775  Israel
Phone: 972-2-548-6555 Fax: 972-2-548-6550


SEARCH JOBS




Industry
Biotechnology






 Company News
Cobra Biologics Ltd. And BioCancell Therapeutics Announce Agreement To Manufacture Promising Cancer Therapy Drug 3/3/2014 10:21:52 AM    More...
BioCancell Therapeutics to Commence Enrollment of Phase IIb Pancreatic Cancer Clinical Trial 10/6/2011 10:17:17 AM    More...
BioCancell Therapeutics Successfully Raises $5.1 Million in Public Offering 11/23/2010 6:59:09 AM    More...
Tikcro Technologies Announces Results of BioCancell Therapeutics' US FDA Phase I/IIa Pancreatic Cancer Trial 11/2/2010 10:17:46 AM    More...
BioCancell Therapeutics Announces Success in Phase I/IIa Pancreatic Cancer Clinical Trial 11/1/2010 11:42:47 AM    More...
Tikcro Technologies Announced BioCancell Therapeutics Receives U.S. FDA Approval to Continue Phase IIb Superficial Bladder Cancer Clinical Trial and Interim Results 4/30/2010 11:04:30 AM    More...
US Department of Health and Human Services Grants Orphan Drug Status to BioCancell Therapeutics's Ovarian Cancer Drug 8/24/2009 10:57:06 AM    More...
USA FDA Allows BioCancell Therapeutics to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials 1/14/2009 10:21:21 AM    More...
VGX International Signs a Master Product Sale Agreement with BioCancell Therapeutics of Israel to Supply Plasmid for Its Multiple Clinical Programs 10/27/2008 11:17:26 AM    More...
Tikcro Technologies Closes Funding into BioCancell Therapeutics 7/31/2008 9:48:18 AM    More...
12